Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 12946-12958
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.12946
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.12946
Figure 1 Potential pathway of denovo non-alcoholic fatty liver disease in animal models with boxes in green representing potential treatment options.
NAFLD: Non-alcoholic fatty liver disease.
Figure 2 Factors involved in development of denovo non-alcoholic fatty liver disease after pancreatectomy.
NAFLD: Non-alcoholic fatty liver disease; VLDL: Very low-density lipoprotein; TP: Total pancreatectomy; DP: Distal pancreatectomy; PD: Pancreatoduodenectomy.
Figure 3 Hepatic steatosis on non-contrast computed tomography scan measured by regions of interest drawn to calculate average Hounsfield units and liver to spleen ratio.
- Citation: Shah P, Patel V, Ashkar M. De novo non-alcoholic fatty liver disease after pancreatectomy: A systematic review. World J Clin Cases 2022; 10(35): 12946-12958
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/12946.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.12946